USPTO serial 88948985
PG
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 2, 2021
- Examiner
- SHINN, LAUREN DONGMI
- Law office
- TMO LAW OFFICE 124
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with PG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tomoko Nakajima
Tomoko Nakajima Future IP LLC4315 50th street NW Suite 100 #7777Washington, DC 20016United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry; Chemicals for use in the manufacture of pharmaceuticals; Chemicals, namely, peptide for use in the manufacture of pharmaceuticals | ACTIVE | — |
| 005 | Synthetic peptides for pharmaceutical purposes, namely, for the treatment of cancer, infectious diseases, and diseases and disorders related to the central nervous system, musculoskeletal system, cardiovascular system, endocrine system, metabolic system, immunological system, skin, blood, ocular system, urological system, genital system, digestive system, respiratory system, and autoimmune system, using regenerative medicine, cell therapy, antibody drug and gene therapy; Chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer, infectious diseases, and diseases and disorders related to the central nervous system, musculoskeletal system, cardiovascular system, endocrine system, metabolic system, immunological system, skin, blood, ocular system, urological system, genital system, digestive system, respiratory system, and autoimmune system, using regenerative medicine, cell therapy, antibody drug and gene therapy; Peptides dietary supplements in the form of granules, tablet, powder, liquid, gels, capsules; Dietary supplements | ACTIVE | — |
| 035 | Retail store services and wholesale store services featuring chemicals; Retail store services and wholesale store services featuring pharmaceutical drugs | ACTIVE | — |
| 040 | Commissioning manufacture of synthetic peptides being contract manufacturing in the field of synthetic peptides; Custom manufacture of synthetic peptides; Custom manufacture of pharmaceuticals; Custom manufacture of chemicals | ACTIVE | — |
| 042 | Testing, inspection, evaluation and research of pharmaceuticals; Information services relating to testing, inspection, evaluation and research of pharmaceuticals; Scientific laboratory services, namely, Testing, inspection, research and development of cell, tissue culture; Scientific Information services relating to testing, inspection, research and development of cell, tissue culture; Testing, inspection and research of pharmaceuticals, cosmetics and foodstuffs; Pharmaceutical research services; Pharmaceutical research; Research in the pharmaceutical field; Testing, inspection and research of pharmaceuticals, cosmetics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PeptiGrowth Inc.
- Other trademarks owned by PeptiGrowth Inc.
- Other trademarks owned by PeptiGrowth Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named PG
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 3, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 2, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 2, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 2, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 2, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 17, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 17, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 28, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 10, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 10, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 10, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 10, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 10, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 2, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 2, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 2, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 17, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 11, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 11, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 4, 2021 | ALIE | ASSIGNED TO LIE | — |
| Mar 2, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 2, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 2, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 11, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 11, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 11, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 11, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 11, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 20, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 7, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 7, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 7, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 5, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 26, 2020 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 25, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 8, 2020 | NWAP | NEW APPLICATION ENTERED | — |